4jwy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==GluN2D ligand-binding core in complex with propyl-NHP5G== | ==GluN2D ligand-binding core in complex with propyl-NHP5G== | ||
<StructureSection load='4jwy' size='340' side='right' caption='[[4jwy]], [[Resolution|resolution]] 2.00Å' scene=''> | <StructureSection load='4jwy' size='340' side='right'caption='[[4jwy]], [[Resolution|resolution]] 2.00Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4jwy]] is a 1 chain structure with sequence from [ | <table><tr><td colspan='2'>[[4jwy]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4JWY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4JWY FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=1N4:(2R)-AMINO(1-HYDROXY-4-PROPYL-1H-PYRAZOL-5-YL)ETHANOIC+ACID'>1N4</scene> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1N4:(2R)-AMINO(1-HYDROXY-4-PROPYL-1H-PYRAZOL-5-YL)ETHANOIC+ACID'>1N4</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4jwy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4jwy OCA], [https://pdbe.org/4jwy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4jwy RCSB], [https://www.ebi.ac.uk/pdbsum/4jwy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4jwy ProSAT]</span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | |||
</table> | </table> | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/NMDE4_RAT NMDE4_RAT] NMDA receptor subtype of glutamate-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Mediated by glycine. | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 20: | Line 18: | ||
</div> | </div> | ||
<div class="pdbe-citations 4jwy" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4jwy" style="background-color:#fffaf0;"></div> | ||
==See Also== | |||
*[[Glutamate receptor 3D structures|Glutamate receptor 3D structures]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Large Structures]] | ||
[[Category: Clausen | [[Category: Rattus norvegicus]] | ||
[[Category: Furukawa | [[Category: Clausen RP]] | ||
[[Category: Hansen | [[Category: Furukawa H]] | ||
[[Category: Jorgensen | [[Category: Hansen KB]] | ||
[[Category: Ogden | [[Category: Jorgensen L]] | ||
[[Category: Perszyk | [[Category: Ogden KK]] | ||
[[Category: Risgaard | [[Category: Perszyk RE]] | ||
[[Category: Tajima | [[Category: Risgaard R]] | ||
[[Category: Traynelis | [[Category: Tajima N]] | ||
[[Category: Vance | [[Category: Traynelis SF]] | ||
[[Category: Vance KM]] | |||
Revision as of 14:28, 30 November 2022
GluN2D ligand-binding core in complex with propyl-NHP5GGluN2D ligand-binding core in complex with propyl-NHP5G
Structural highlights
FunctionNMDE4_RAT NMDA receptor subtype of glutamate-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Mediated by glycine. Publication Abstract from PubMedN-methyl-d-aspartate (NMDA) receptors are ligand-gated ion channels assembled from GluN1 and GluN2 subunits. We used a series of N-hydroxypyrazole-5-glycine (NHP5G) partial agonists at the GluN2 glutamate binding site as tools to study activation of GluN1/GluN2A and GluN1/GluN2D NMDA receptor subtypes. Using two-electrode voltage-clamp electrophysiology, fast-application patch-clamp, and single-channel recordings, we show that propyl- and ethyl-substituted NHP5G agonists have a broad range of agonist efficacies relative to the full agonist glutamate (<1-72%). Crystal structures of the agonist binding domains (ABDs) of GluN2A and GluN2D do not reveal any differences in the overall domain conformation induced by binding of the full agonist glutamate or the partial agonist propyl-NHP5G, which is strikingly different from ABD structures of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propanoate (AMPA) and kainate receptors bound to full and partial agonists. Subsequent evaluation of relative NHP5G agonist efficacy at GluN2A-GluN2D chimeric subunits implicates the amino-terminal domain (ATD) as a strong determinant of agonist efficacy, suggesting that interdomain interactions between the ABD and the ATD may be a central element in controlling the manner by which agonist binding leads to channel opening. We propose that variation in the overall receptor conformation, which is strongly influenced by the nature of interdomain interactions in resting and active states, mediates differences in agonist efficacy and partial agonism at the GluN2 subunits. Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-d-aspartate receptors.,Hansen KB, Tajima N, Risgaard R, Perszyk RE, Jorgensen L, Vance KM, Ogden KK, Clausen RP, Furukawa H, Traynelis SF Mol Pharmacol. 2013 Jul;84(1):114-27. doi: 10.1124/mol.113.085803. Epub 2013 Apr , 26. PMID:23625947[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||